More on INAB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+63.5% Growth)
- Ratings (8.0 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

IN8bio, Inc (NQ:INAB)
Delayed: 1.09 -0.01 (0.91%)
Prev. Close $1.10  
Open$1.10 
52 Wk High$ 
52 Wk Low$ 
Day High$1.13 
Day Low$1.08 
P/E N/A  
EPS$ 
Volume19,948 

Friends, Peers and Foes (?): DMAC, NSRX CNTB (more...)

Aug 13, 2026 02:22 PM Form SCHEDULE 13G/A IN8BIO, INC. Filed by: LYTTON LAURENCE W
Aug 10, 2026 04:01 PM IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aug 7, 2026 06:17 AM Form S-8 IN8BIO, INC.
Aug 6, 2026 04:24 PM IN8bio, Inc (INAB) Tops Q2 EPS by 9c
Aug 6, 2026 04:17 PM Form 10-Q IN8BIO, INC. For: Jun 30
Aug 6, 2026 04:07 PM Form 8-K IN8BIO, INC. For: Aug 06
Aug 6, 2026 04:01 PM IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Jul 9, 2026 08:02 AM IN8bio publishes Phase 1 glioblastoma trial data in oncology journal
Jul 9, 2026 08:00 AM IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
Jun 4, 2026 06:44 AM H.C. Wainwright Reiterates Buy Rating on IN8bio Inc. (INAB)
View All Articles

Entities mentioned with INAB

View All Entities